Contrast Enhanced Ultrasound Market To Reach $2.99 Billion By 2030

Contrast Enhanced Ultrasound Market Growth & Trends

The global contrast enhanced ultrasound market is anticipated to reach USD 2.99 billion by 2030 and grow at a CAGR of 5.8% during the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic diseases such as cancer, cardiovascular, and liver disorders drives the demand for accurate and early diagnosis. Patients and clinicians increasingly favor noninvasive procedures like Contrast Enhanced Ultrasound (CEUS) due to their safety, speed, and lack of radiation exposure. This growing preference and the need for ongoing disease monitoring fuel rapid adoption of CEUS technologies across global healthcare systems, thereby expanding market size and clinical utilization.

Global investments in healthcare infrastructure fuel the adoption of advanced diagnostic tools like CEUS. Modern hospitals and diagnostic centers are increasingly equipping themselves with CEUS systems to improve patient care. In addition, an aging population contributes to a surge in chronic conditions that require regular imaging. These demographic and infrastructure trends are significantly increasing the demand for CEUS, making it a vital component of modern diagnostic strategies worldwide.

Ongoing innovations in ultrasound technology and contrast agent development enhance the accuracy, efficiency, and safety of CEUS. These improvements have broadened CEUS applications across multiple medical fields, including oncology, cardiology, and nephrology. The ability to use CEUS for real-time, detailed imaging in various organs supports faster, more informed clinical decisions. This expansion into diverse diagnostic areas is expected to drive widespread adoption and boost market growth over the coming years.

 Request a free sample copy or view report summary: Contrast Enhanced Ultrasound Market Report

Contrast Enhanced Ultrasound Market Report Highlights

• By product, the equipment segment held the largest share of 71.7% in 2024 due to the rising adoption of advanced ultrasound systems and increasing demand for precise diagnostic tools.

• The contrast agents segment is anticipated to be the fastest-growing segment from 2025 to 2030,fueled bythe rising prevalence of chronic diseases and growing awareness of noninvasive diagnostic procedures.

• By type, the non-targeted segment led the market with the largest revenue share in 2024, attributed to its broad clinical applicability and ease of use.

• By end use, the hospitals segment dominated the market with the largest share in 2024, owing to high patient volumes, access to advanced imaging technologies, and the availability of skilled professionals.

• North America accounted for the largest revenue share of 34.6% in 2024, propelled bya well-established healthcare infrastructure, widespread adoption of advanced imaging technologies, and favorable reimbursement policies for CEUS procedures.

Contrast Enhanced Ultrasound Market Segmentation

Grand View Research has segmented the global contrast enhanced ultrasound market based on product, type, end use, and region:

Contrast Enhanced Ultrasound Product Outlook (Revenue, USD Million, 2018 - 2030)

• Equipment

• Contrast Agents

Contrast Enhanced Ultrasound Type Outlook (Revenue, USD Million, 2018 - 2030)

• Non-targeted

• Targeted

Contrast Enhanced Ultrasound End UseOutlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Clinics

• Ambulatory Diagnostic Centers

Contrast Enhanced Ultrasound Region Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Contrast Enhanced Ultrasound Market

• Lantheus

• GE HealthCare

• Bracco

• Siemens Healthineers AG

• Koninklijke Philips N.V.

• CANON MEDICAL SYSTEMS CORPORATION

• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.